IL6 and type 2 diabetes mellitus: Low-grade inflammation, as measured by higher levels of interleukin-6 (IL-6), tumor necrosis factor (TNF), C-reactive protein (CRP), and adhesion molecules, has been identified as a major contributor to the development of T2DM [25].